Sign in
4

Changes in Ownership

Krystal Biotech, Inc. Filed Acc 0001209191-19-057590

Chief Financial Officer acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Riley Antony A · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-19 Exercise or conversion : show line 1 in the form +6,250 $9.85 $61,563 9,050 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-11-19 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −6,250 18,750 D
Loading xslF345X03/doc4.xml…